0.00
price down icon100.00%   -93.80
after-market 시간 외 거래: 2.65 2.65 +
loading
전일 마감가:
$93.80
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$80.00M
수익:
-
순이익/손실:
$-75.52M
주가수익비율:
0.00
EPS:
-2.88
순현금흐름:
$-56.92M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
Value
$0.00
$0.00
1주일 범위
Value
$0.00
$0.00
52주 변동 폭
Value
$0.00
$105.00

Aerovate Therapeutics Inc Stock (AVTE) Company Profile

Name
명칭
Aerovate Therapeutics Inc
Name
전화
617-443-2400
Name
주소
930 WINTER STREET, WALTHAM
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
AVTE's Discussions on Twitter

AVTE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AVTE
Aerovate Therapeutics Inc
0.00 80.00M 0 -75.52M -56.92M -2.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-14 개시 Jefferies Buy
2025-06-16 업그레이드 Guggenheim Neutral → Buy
2025-05-07 개시 Wedbush Outperform
2025-05-05 개시 Stifel Buy
2025-05-02 개시 TD Cowen Buy
2024-06-18 다운그레이드 Evercore ISI Outperform → In-line
2024-06-18 다운그레이드 TD Cowen Buy → Hold
2024-06-18 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-06-17 다운그레이드 BTIG Research Buy → Neutral
2024-06-17 다운그레이드 Guggenheim Buy → Neutral
2024-06-17 다운그레이드 Wedbush Outperform → Neutral
2024-03-25 재개 Jefferies Buy
2023-12-08 개시 Wells Fargo Equal Weight
2023-03-01 개시 Guggenheim Buy
2022-12-06 업그레이드 BTIG Research Neutral → Buy
2022-09-19 재개 Wedbush Outperform
2022-08-16 다운그레이드 BTIG Research Buy → Neutral
2022-02-11 개시 BTIG Research Buy
2021-07-26 개시 Cowen Outperform
2021-07-26 개시 Evercore ISI Outperform
2021-07-26 개시 Jefferies Buy
2021-07-26 개시 Wedbush Outperform
모두보기

Aerovate Therapeutics Inc 주식(AVTE)의 최신 뉴스

pulisher
Aug 12, 2025

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 2.3% – Still a Buy? - Defense World

Aug 12, 2025
pulisher
Aug 09, 2025

Aerovate Therapeutics (AVTE) Projected to Post Earnings on Monday - Defense World

Aug 09, 2025
pulisher
Jun 27, 2025

Rhumbline Advisers Acquires 9,154 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 27, 2025
pulisher
Jun 24, 2025

Deep Track Capital, LP Acquires New Holdings in Aerovate Therapeutics Inc - GuruFocus

Jun 24, 2025
pulisher
Jun 23, 2025

Pulmonary Arterial Hypertension Market Set to Grow Substantially Through 2034, DelveInsight Projects | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros - Barchart.com

Jun 23, 2025
pulisher
Jun 17, 2025

Aerovate Therapeutics (NASDAQ:JBIO) Upgraded to Buy at Guggenheim - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Guggenheim Upgrades Jade Biosciences to Buy From Neutral, Price Target is $14 - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Guggenheim upgrades Jade Biosciences stock rating to Buy on transformation - Investing.com Canada

Jun 16, 2025
pulisher
Jun 14, 2025

Aerovate Therapeutics (NASDAQ:JBIO) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Cuts Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

FMR LLC's Strategic Acquisition of Aerovate Therapeutics Inc Shares - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

19,564 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Purchased by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Bank of America Corp DE Has $612,000 Stock Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Two Sigma Investments LP Cuts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Grows Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Purchases 6,296 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

May 31, 2025
pulisher
May 14, 2025

Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences Secures Massive $300M Funding After Nasdaq Debut, First Clinical Trial Set for 2025 - Stock Titan

May 14, 2025
pulisher
May 10, 2025

Aerovate Therapeutics (AVTE) to Release Earnings on Monday - Defense World

May 10, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Buys 26,700 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

May 08, 2025
pulisher
May 05, 2025

Stifel Nicolaus Initiates Coverage on Jade Biosciences With Buy Rating, $19 Price Target - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Stifel initiates Jade Biosciences stock with a Buy, $19 target - Investing.com

May 05, 2025
pulisher
May 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - marketscreener.com

May 03, 2025
pulisher
May 03, 2025

Aerovate Therapeutics, Inc. Announces Board Changes - marketscreener.com

May 03, 2025
pulisher
May 02, 2025

Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade Biosciences - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TD Cowen Initiates Coverage on Jade Biosciences With Buy Rating - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TD Cowen starts Jade Biosciences coverage with Buy rating - Investing.com

May 02, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Completes Merger with Jade Biosciences - TipRanks

May 01, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Announces Range of Expected Cash Dividend - marketscreener.com

May 01, 2025
pulisher
Apr 30, 2025

Aerovate Therapeutics Announces Range Of Expected Cash Dividend - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

RTW Biotech Opportunities’ Jade Biosciences merges with Aerovate Therapeutics - QuotedData

Apr 30, 2025
pulisher
Apr 29, 2025

Jade Biosciences Highlights JADE-001 Progress in Presentation - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Aerovate Therapeutics Inc (AVTE)’s financial ratios: A comprehensive overview - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

JBIO Stock Price and Chart — NASDAQ:JBIO - TradingView

Apr 29, 2025
pulisher
Apr 29, 2025

Aerovate Therapeutics (AVTE) Options Set for Delisting | AVTE St - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Aerovate Therapeutics (AVTE) Options Set for Delisting | AVTE Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Jade Biosciences merges with Aerovate Therapeutics07:00:02 29 Apr 2025RTW News article - London Stock Exchange

Apr 29, 2025
pulisher
Apr 29, 2025

Traders Buy Large Volume of Call Options on Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Jade Biosciences closes merger with Aerovate Therapeutics - Coast Reporter

Apr 28, 2025
pulisher
Apr 28, 2025

Aerovate Therapeutics Inc (AVTE) gets rating Downgrade from Wells Fargo - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously ... - Bluefield Daily Telegraph

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million - Benzinga

Apr 28, 2025
pulisher
Apr 28, 2025

Russell Investments Group Ltd. Boosts Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Aerovate Therapeutics, Inc. SEC 10-Q Report - TradingView

Apr 25, 2025
pulisher
Apr 25, 2025

Aerovate Therapeutics Inc (AVTE) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Aerovate Therapeutics (AVTE) Soars 721.88% on Merger, Dividend News - AInvest

Apr 25, 2025
pulisher
Apr 24, 2025

AVTE’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH) - Barchart.com

Apr 24, 2025
pulisher
Apr 24, 2025

AVTE Shares Experience Decline in Value - knoxdaily.com

Apr 24, 2025

Aerovate Therapeutics Inc (AVTE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
자본화:     |  볼륨(24시간):